Early trial tests One-Shot cell therapy for eight serious autoimmune conditions
NCT ID NCT06548620
Summary
This early-phase study aimed to test the safety and initial effects of a new cell therapy called RD06-04 for people with serious autoimmune diseases like lupus, multiple sclerosis, and myasthenia gravis. The therapy involves modifying a patient's own immune cells (CAR-T cells) to target and reduce the harmful antibodies driving these diseases. The study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 461499, China
Conditions
Explore the condition pages connected to this study.